Elekta rises on Q4 beat despite order decline, R&D impairment charge

Elekta reported an 82% drop in net income to SEK 240 million for fiscal year 2025, primarily due to a SEK 1.06 billion non-cash impairment charge related to discontinued R&D projects, despite net sales decreasing only 1% (up 1% at constant currency). Q4 showed improvement with adjusted EBIT up 29% year-over-year and gross margins reaching a five-year high, supported by price increases and product mix. While leadership transitions are underway, Elekta anticipates net sales growth and margin expansion driven by product launches and pricing strategies.

Analysis

Elekta's fiscal year 2025 net income plummeted 82% to SEK 240 million, predominantly due to a substantial SEK 1.06 billion non-cash impairment charge related to discontinued R&D projects as the company shifts its software strategy towards external cloud platforms. Despite this significant accounting impact, underlying operational metrics showed resilience and fourth-quarter improvement. Full-year net sales decreased marginally by 1% to SEK 18.02 billion (a 1% increase in constant currency), supported by demand in Europe and the Asia-Pacific region. However, fourth-quarter net sales rose 3% year-over-year to SEK 5.16 billion (6% in constant currency), with EMEA sales growing 16% and Asia-Pacific 5% in constant currency, though North American sales declined 6% due to regulatory delays for the Elekta Evo system. Adjusted EBIT for the full year saw a slight decline to SEK 2.10 billion with an adjusted EBIT margin of 11.6%, down from 11.8%. In contrast, the fourth quarter demonstrated strong recovery, with adjusted EBIT increasing 29% year-over-year to SEK 843 million and the adjusted EBIT margin expanding robustly to 16.3% from 13.0%. This Q4 margin strength was underpinned by an adjusted gross margin of 40.3%, a five-year high for the period, driven by higher sales volumes, price increases, and a favorable product mix. Furthermore, Elekta generated strong cash flow of SEK 1.06 billion for the year after investments and achieved SEK 279 million in annual run-rate cost savings. The company is currently navigating a leadership transition, with an interim CEO in place, while proposing an unchanged dividend of SEK 2.40 per share despite earnings per share falling to SEK 0.62 from SEK 3.41. Elekta anticipates continued net sales growth and margin expansion, banking on new product launches and pricing strategies.

Key Decisions for Investors

• Investors should look beyond the impairment-driven net income fall and closely analyze the improving Q4 operational trends, including the 6% constant currency sales growth and the significant adjusted EBIT margin expansion to 16.3%.
• The ongoing CEO search and subsequent leadership stability are critical factors to monitor, as they will influence the execution of the guided sales growth and margin expansion.
• Scrutinize developments regarding the Elekta Evo system's regulatory clearance in North America, as a recovery in this market is pivotal for future growth.
• Evaluate the sustainability of the unchanged SEK 2.40 dividend per share in light of the sharply lower EPS of SEK 0.62 and future cash flow generation capabilities, despite management's apparent confidence.